---
id: travelers-diarrhea_089
category: clinical_syndromes
tags: [travelers-diarrhea, ETEC, azithromycin, rifaximin, prophylaxis]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Traveler's Diarrhea

**Q:** What are the causes, prevention strategies, and treatment approaches for traveler's diarrhea?

**A:**

**Definition:**
- **Traveler's Diarrhea (TD):** ≥3 unformed stools in 24 hours + ≥1 enteric symptom (cramping, nausea, urgency, fever)
- **Occurs during or within 10 days of travel** to high-risk region

---

## EPIDEMIOLOGY

**Incidence:**
- **30-70% of travelers** to high-risk regions (depends on destination)
- **10-20 million cases/year** (US travelers)

**High-Risk Regions:**
- **Latin America, Africa, Middle East, South Asia** (India, Nepal, Bangladesh)
- **Moderate risk:** Eastern Europe, Russia, China
- **Low risk:** North America, Western Europe, Australia, New Zealand, Japan

**Key Point:** **30-70% of travelers to high-risk regions** develop TD

---

## ETIOLOGY

**Bacterial (80-90%):**

| **Pathogen** | **Frequency** | **Key Features** |
|--------------|---------------|------------------|
| **Enterotoxigenic *E. coli* (ETEC)** | **30-40%** (#1) | Watery diarrhea, secretory toxin |
| **Enteroaggregative *E. coli* (EAEC)** | **10-20%** | Watery diarrhea, biofilm formation |
| ***Campylobacter jejuni*** | **10-20%** | Bloody diarrhea, undercooked poultry |
| ***Shigella* species** | **5-15%** | Bloody diarrhea (dysentery), highly contagious |
| **Non-typhoidal *Salmonella*** | **5-10%** | Bloody or watery, reptile exposure |
| ***Vibrio* species** | **<5%** | Cholera (severe watery), seafood |

**Viral (10-20%):**
- **Norovirus** (most common viral cause)
- **Rotavirus** (especially children)

**Parasitic (<5%):**
- ***Giardia lamblia*** (most common parasite)
- ***Cryptosporidium***
- ***Cyclospora cayetanensis***
- ***Entamoeba histolytica***

**Key Point:** **ETEC = #1 cause** (30-40%)

---

## CLINICAL PRESENTATION

**Incubation Period:**
- **6-72 hours** (most cases within first week of travel)

**Symptoms:**
- **Watery diarrhea** (most common)
- **Abdominal cramping**
- **Nausea, vomiting**
- **Low-grade fever**
- **Urgency**

**Duration:**
- **Self-limited:** 3-5 days (70-80% resolve without treatment)
- **Persistent diarrhea:** >14 days (10-15% - suspect parasites)

**Severity Classification:**

| **Severity** | **Definition** |
|--------------|----------------|
| **Mild** | Tolerable, not distressing, does NOT interfere with activities |
| **Moderate** | Distressing, interferes with activities |
| **Severe** | Incapacitating, prevents activities |

---

## PREVENTION

---

### **1. Food and Water Precautions:**

**"Boil It, Cook It, Peel It, or Forget It"**

**Safe:**
- **Boiled or bottled water** (sealed bottles)
- **Hot, thoroughly cooked food**
- **Fruits YOU peel** (bananas, oranges)
- **Dry foods** (bread, crackers)

**Avoid:**
- **Tap water** (including ice cubes, brushing teeth)
- **Raw vegetables, salads**
- **Unpasteurized dairy**
- **Undercooked meat, seafood**
- **Food from street vendors**

**Key Point:** **"Boil it, cook it, peel it, or forget it"**

---

### **2. Chemoprophylaxis (NOT Routinely Recommended):**

**Indications for Prophylaxis:**
- **High-risk travelers** (immunocompromised, IBD, achlorhydria)
- **Short trips where TD would be disruptive** (athletes, business travelers, honeymoons)

**Prophylactic Options:**

#### **A. Bismuth Subsalicylate (Pepto-Bismol):**

**Dosing:**
- **2 tablets (262 mg each) PO QID** (with meals + bedtime)
- Start 1 day before travel, continue during + 2 days after

**Efficacy:**
- **60-65% reduction** in TD risk

**Limitations:**
- **Frequent dosing** (QID)
- **Black tongue, black stools**
- **Contraindications:** Aspirin allergy, anticoagulation, chronic kidney disease

---

#### **B. Rifaximin:**

**Dosing:**
- **200 mg PO daily** OR **200 mg PO BID**

**Efficacy:**
- **70-80% reduction** in TD risk

**Advantages:**
- **Non-absorbed** (minimal systemic effects)
- **No resistance concerns** (not used for systemic infections)

**Limitations:**
- **Expensive**
- **NOT effective against invasive pathogens** (Campylobacter, Shigella)

---

#### **C. Fluoroquinolones (Ciprofloxacin) - NOT Recommended for Prophylaxis:**

**Reasons:**
- ↑ **Fluoroquinolone resistance** (especially Campylobacter, Salmonella)
- **Adverse effects:** Tendinopathy, QT prolongation, C. difficile risk
- **FDA warning** against routine prophylaxis

---

**Current Recommendation:**
- **Prophylaxis NOT routinely recommended** for most travelers
- **Consider rifaximin or bismuth** for high-risk travelers or critical trips
- **Do NOT use antibiotics routinely** (resistance concerns)

**Key Point:** **Prophylaxis NOT routine** (only high-risk travelers, critical trips)

---

## TREATMENT

---

### **Step 1: Hydration (CORNERSTONE)**

**Oral Rehydration Solution (ORS):**
- **WHO-ORS** (low-osmolarity)
- **Homemade:** 1 liter water + 6 tsp sugar + 1/2 tsp salt

**Key Point:** **Hydration = most important treatment**

---

### **Step 2: Symptomatic Treatment (Antimotility Agents)**

**Loperamide (Imodium):**

**Dosing:**
- **4 mg PO initially**, then **2 mg PO after each loose stool** (max 16 mg/day)

**Efficacy:**
- **Reduces diarrhea duration by ~1 day**

**Safety:**
- **Safe if non-bloody diarrhea, no high fever**

**Contraindications:**
- **Bloody diarrhea**
- **High fever (>38.5°C)**
- ***C. difficile* colitis**
- **Suspected STEC** (↑ HUS risk)

**Key Point:** **Loperamide safe if non-bloody** (do NOT use if bloody or high fever)

---

### **Step 3: Antibiotic Therapy**

---

#### **Indications for Antibiotics:**

**Treat if:**
- **Moderate-to-severe TD** (distressing, interferes with activities)
- **Bloody diarrhea**
- **High fever** (>38.5°C)
- **>4 unformed stools/day**

**Do NOT need antibiotics if:**
- **Mild TD** (tolerable, does NOT interfere with activities)
- **Already improving** (>48h after onset)

---

#### **Antibiotic Regimens:**

---

**A. Azithromycin (FIRST-LINE - Preferred):**

**Dosing:**
- **1000 mg (1g) PO x 1 dose** (single dose)
- **OR 500 mg PO daily x 3 days**

**Advantages:**
- **Effective against most TD pathogens** (including Campylobacter, Shigella)
- **Fluoroquinolone resistance** now common (especially Campylobacter) → Azithromycin preferred

**Key Point:** **Azithromycin = first-line** (single 1g dose)

---

**B. Rifaximin:**

**Dosing:**
- **200 mg PO TID x 3 days**

**Advantages:**
- **Non-absorbed** (minimal systemic effects)
- **Effective for ETEC** (most common cause)

**Limitations:**
- **NOT effective against invasive pathogens** (Campylobacter, Shigella - need systemic absorption)
- **Do NOT use if bloody diarrhea or high fever** (suggests invasive pathogen)

**Indication:**
- **Non-bloody, watery TD** (likely ETEC)

---

**C. Fluoroquinolones (Ciprofloxacin, Levofloxacin) - Second-Line:**

**Dosing:**
- **Ciprofloxacin** 500 mg PO BID x 3 days OR **750 mg PO x1** (single dose)
- **Levofloxacin** 500 mg PO daily x 3 days

**Limitations:**
- **↑ Fluoroquinolone resistance** (especially Campylobacter in South/Southeast Asia - 80-90% resistant)
- **Adverse effects:** Tendinopathy, QT prolongation, C. difficile

**Indication:**
- **Second-line** (if azithromycin unavailable or contraindicated)

---

**Preferred Regimen Summary:**

| **Clinical Scenario** | **First-Line Antibiotic** |
|-----------------------|---------------------------|
| **Moderate-severe watery TD** | **Azithromycin** 1g PO x1 OR **Rifaximin** 200 mg PO TID x 3 days |
| **Bloody diarrhea or high fever** | **Azithromycin** 1g PO x1 (or 500 mg PO daily x 3 days) |
| **Mild, improving TD** | **No antibiotics** (hydration + loperamide) |

**Key Point:** **Azithromycin = first-line for moderate-severe TD**

---

### **Step 4: Combination Therapy (Antibiotic + Loperamide)**

**Regimen:**
- **Azithromycin** 1g PO x1 (or 500 mg daily x 3 days)
  **PLUS**
- **Loperamide** 4 mg initially, then 2 mg after each loose stool (max 16 mg/day x 2 days)

**Efficacy:**
- **Combination MORE effective** than either alone
- **Reduces duration by 1-2 days** (vs antibiotics alone)

**Safety:**
- **Safe if non-bloody diarrhea**
- **Do NOT use loperamide if bloody or high fever**

**Key Point:** **Combination (azithromycin + loperamide) most effective** for moderate-severe watery TD

---

## PERSISTENT TRAVELER'S DIARRHEA (>14 Days)

**Definition:** Diarrhea persisting >14 days after travel

**Common Causes:**
- **Parasites:** ***Giardia lamblia*** (#1), *Cryptosporidium*, *Cyclospora*, *Entamoeba histolytica*
- **Post-infectious IBS** (functional diarrhea after infection)
- **Small intestinal bacterial overgrowth (SIBO)**

**Workup:**
- **Stool ova & parasites (O&P)** x 3 samples
- **Giardia antigen test** (stool)
- **Multiplex GI PCR panel**
- **Stool culture** (if not done)

**Treatment:**
- **If *Giardia*:** Metronidazole 250 mg PO TID x 5-7 days OR Tinidazole 2g PO x1
- **If *Cryptosporidium*:** Nitazoxanide 500 mg PO BID x 3 days (immunocompetent)
- **If *Cyclospora*:** TMP-SMX DS 1 tab PO BID x 7-10 days
- **If *E. histolytica*:** Metronidazole 750 mg PO TID x 10 days + Paromomycin 500 mg PO TID x 7 days

**Key Point:** **Persistent TD >14 days = think parasites** (*Giardia* #1)

---

## SPECIAL POPULATIONS

---

### **Pregnancy:**

**Safe:**
- **Azithromycin** (preferred)
- **Loperamide** (Category B)

**Avoid:**
- **Fluoroquinolones** (avoid in pregnancy)
- **Bismuth subsalicylate** (avoid in 3rd trimester)

---

### **Children:**

**Antibiotics:**
- **Azithromycin** 10 mg/kg PO daily x 3 days (or 20 mg/kg PO x1)

**Loperamide:**
- **NOT recommended <2 years**
- **Use with caution 2-5 years**

---

### **Immunocompromised:**

**Higher Risk:**
- **More severe illness**
- **Prolonged duration**
- **Consider prophylaxis** (rifaximin or bismuth)

**Treatment:**
- **Azithromycin** (extended course - 5-7 days if severe)

---

## PROGNOSIS

**Duration (Without Treatment):**
- **3-5 days** (70-80% resolve)

**Duration (With Treatment):**
- **1-2 days** (antibiotics + loperamide)

**Complications:**
- **Reactive arthritis** (post-Campylobacter, Shigella, Salmonella) - 2-5%
- **Guillain-Barré syndrome** (post-Campylobacter) - rare
- **Post-infectious IBS** - 10-15%

---

**Mnemonic: "ETEC = Traveler's Enemy"**
- **E**nterotoxigenic *E. coli* (ETEC)
- **T**raveler's diarrhea (#1 cause - 30-40%)
- **E**nterotoxin (secretory, watery diarrhea)

**Mnemonic: "AAL for TD Treatment"**
- **A**zithromycin (first-line)
- **A**void fluoroquinolones (resistance)
- **L**operamide (add if non-bloody)

**Mnemonic: "Boil it, Cook it, Peel it, or Forget it"**
- Prevention strategy for food/water

**Clinical Pearls:**
- **TD affects 30-70% of travelers** to high-risk regions (Latin America, Africa, South Asia)
- **ETEC = #1 cause** (30-40%)
- **Prevention:** "Boil it, cook it, peel it, or forget it"
- **Prophylaxis NOT routinely recommended** (only high-risk travelers, critical trips)
- **Rifaximin or bismuth subsalicylate** for prophylaxis (if needed)
- **Azithromycin 1g PO x1 = first-line treatment** (moderate-severe TD)
- **Combination (azithromycin + loperamide) most effective** for watery TD
- **Loperamide safe if non-bloody** (contraindicated if bloody, high fever, C. difficile, STEC)
- **Fluoroquinolones = second-line** (due to ↑ Campylobacter resistance - 80-90% in South Asia)
- **Rifaximin effective for watery TD** (ETEC), but NOT invasive pathogens
- **Persistent TD >14 days = think parasites** (*Giardia* #1)
- **Most TD self-limited** (3-5 days without treatment)
- **Treatment shortens duration to 1-2 days**

**Media:** None

**Sources:** [IDSA 2017 - Travelers' Diarrhea Guidelines], [CDC Yellow Book 2024 - Travelers' Diarrhea], [NEJM 2023 - Management of travelers' diarrhea], [Clinical Infectious Diseases 2024 - Azithromycin vs fluoroquinolones], [Lancet ID 2024 - Antimicrobial resistance in TD pathogens]
